Denosumab Versus Bisphosphonates for the Prevention of the Vertebral Fractures in Men with Osteoporosis: An Updated Network Meta-Analysis
CONCLUSION: Denosumab effectively reduced the risk of vertebral fractures in men with osteoporosis, and this effect was comparable to that of bisphosphonates.PMID:36149052 | DOI:10.25011/cim.v45i3.38875
Source: Clinical and Investigative Medicine - Category: Biomedical Science Authors: Pengfei Li Xiaojian Wu Ye Li Jianhua Huang Source Type: research
More News: Actonel | Biomedical Science | Orthopaedics | Osteoporosis | Reclast | Risedronate | Study | Xgeva | Zometa